NCT04774120

Brief Summary

The aim of this study is to describe the BIS values and electroencephalographic patterns during total intravenous anesthesia with propofol-remifentanyl, in patients from 18 to 85 years.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
30

participants targeted

Target at below P25 for all trials

Timeline
Completed

Started Dec 2020

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

December 11, 2020

Completed
1 month until next milestone

First Submitted

Initial submission to the registry

January 19, 2021

Completed
1 month until next milestone

First Posted

Study publicly available on registry

March 1, 2021

Completed
29 days until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 30, 2021

Completed
2 months until next milestone

Study Completion

Last participant's last visit for all outcomes

May 30, 2021

Completed
Last Updated

March 16, 2022

Status Verified

February 1, 2021

Enrollment Period

4 months

First QC Date

January 19, 2021

Last Update Submit

March 15, 2022

Conditions

Keywords

electroencephalographybispectral indexpropofolalpha bandagingburst suppression

Outcome Measures

Primary Outcomes (1)

  • BIS values at which EEG patterns appears during induction of anesthesia with propofol.

    BIS values correlated to specific EEG patterns (frequency bands, complexity measures and burst suppression)

    From induction of anesthesia until suppression rate appears, an average of 15 minutes.

Secondary Outcomes (6)

  • Propofol effect-site concentration (µg/ml) required to observe specific EEG patterns

    From induction of anesthesia until loss of consciousness, an average of 15 minutes.

  • Propofol effect-site concentration (µg/ml) required to achieve loss of consciousness

    From Induction of anesthesia until suppression rate appears, an average of 15 minutes.

  • BIS values at loss of consciousness

    From Induction of anesthesia until suppression rate appears, an average of 15 minutes.

  • Percentage of time with BIS values between 40-60 and out of this range.

    From induction of anesthesia until patient's extubation, an average of 90 minutes.

  • Time to achieve loss of consciousness

    From Induction of anesthesia until loss of consciousness, an average of 10 minutes.

  • +1 more secondary outcomes

Study Arms (2)

Young Patients (Patients aged 18 to 65 years.)

Propofol infusion rate will be started at 20-25 mg/kg/hr until SR achieved. Then restarted at half of the initial rate. Maintenance of anesthesia will be guided by Sedline Monitor to maintain an alpha band present in the spectrogram and SEF95 between 8-12 Hz. BIS monitor will be covered. Both EEG signals (Sedline and BIS) will be registered simultaneously until the patient's extubation.

Drug: Propofol

Elderly patients (Patients aged 65 to 85 years. )

Propofol infusion rate will be started at 15-20 mg/kg/hr until SR achieved. Then restarted at half of the initial rate. Maintenance of anesthesia will be guided by Sedline Monitor to maintain an alpha band present in the spectrogram and SEF95 between 8-12 Hz. BIS monitor will be covered. Both EEG signals (Sedline and BIS) will be registered simultaneously until the patient's extubation.

Drug: Propofol

Interventions

Propofol will be started at a rate of 15-20 mg/kg/hr in patients \>65 years and 20-25 mg/kg/hr in younger patients (\<65 years) until a suppression rate (SR) is achieved. If not, can be increased by 5 mg/kg/hr every 5 minutes up to 25 mg/kg/hr in the elderly group and 30 mg/kg/hr in the younger group or after 15 minutes have passed. When the SR appears, propofol infusion will be stopped. Then restarted at half of the initial rate. Maintenance of anesthesia will be guided by Sedline Monitor to maintain an alpha band present in the spectrogram and SEF95 between 8-12 Hz. BIS monitor will be covered. Both EEG signals (Sedline and BIS) will be registered simultaneously until the patient's extubation.

Also known as: Diprivan, Propoven
Elderly patients (Patients aged 65 to 85 years. )Young Patients (Patients aged 18 to 65 years.)

Eligibility Criteria

Age18 Years - 90 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Elderly patients scheduled for surgery are an understudied population. Incidence of postoperative delirium and other complications can be related to changes in cerebral dynamics under anesthesia, with effects observed even after the use of anesthetics agents. Formal characterization of the dynamic relationship between propofol concentrations at the effect site (Ce), spectral power, and BIS values may provide clinically relevant information to design propofol dose schemes in young and elderly patients.

You may qualify if:

  • Adult patients scheduled for elective surgery requiring general anesthesia.
  • American Society of Anesthesiology (ASA) Score I or II

You may not qualify if:

  • Patients with neurological diseases or history of cognitive impairment.
  • Requiring the use of two or more drugs affecting Central nervous system
  • History of drugs or alcohol abuse
  • Body mass index over 35 kg/m\^2
  • Propofol allergy
  • Cardiac congestive failure
  • History of coronary syndrome

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Division de Anestesia - Pontificia Universidad Catolica de Chile

Santiago, Santiago Metropolitan, 8330024, Chile

Location

Related Publications (1)

  • Purdon PL, Pavone KJ, Akeju O, Smith AC, Sampson AL, Lee J, Zhou DW, Solt K, Brown EN. The Ageing Brain: Age-dependent changes in the electroencephalogram during propofol and sevoflurane general anaesthesia. Br J Anaesth. 2015 Jul;115 Suppl 1(Suppl 1):i46-i57. doi: 10.1093/bja/aev213.

    PMID: 26174300BACKGROUND

MeSH Terms

Interventions

Propofol

Intervention Hierarchy (Ancestors)

PhenolsBenzene DerivativesHydrocarbons, AromaticHydrocarbons, CyclicHydrocarbonsOrganic Chemicals

Study Officials

  • Daniela Muñoz, MD

    Pontificia Universidad Catolica de Chile

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
CROSS SECTIONAL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

January 19, 2021

First Posted

March 1, 2021

Study Start

December 11, 2020

Primary Completion

March 30, 2021

Study Completion

May 30, 2021

Last Updated

March 16, 2022

Record last verified: 2021-02

Data Sharing

IPD Sharing
Will not share

Locations